Trials / Completed
CompletedNCT00962195
The Effect of Purple Sweet Potato (PSP)-Juice on Liver Enzymes and Blood Pressure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- TNO · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Purple Sweet Potato juice (PSP-juice) is a juice based on purple-fleshed sweet potato concentrate, containing a high level of anthocyanins. Purple-fleshed sweet potatoes have attracted attention to industry and scientists due to multiple physiological functions such as radical-scavenging, ACE-inhibitory and α-glucosidase inhibitory activities in vitro, and also hepato-protective, antihypertensive and antihyperglycemic effects in vivo. Previous studies in Japanese subjects showed potential beneficial effects of PSP beverages on liver function and blood pressure in volunteers with impaired hepatic function and/or hypertension. The main objective of this study is to examine the effect of PSP-juice on liver enzymes and blood pressure. The secondary objective is to examine the effects of PSP-juice juice on insulin resistance.
Detailed description
Study design: The study is designed as a randomized, parallel, placebo-controlled, double-blind study. Study population: 40 healthy adult female and/or male subjects, 40-70 yr old with a BMI 25-35 kg/m2, mildly elevated serum liver enzymes, and high normal blood pressure or mild hypertension. Intervention: Daily oral intake of 3x 125 ml of PSP-juice or control juice for a period of 8 weeks. Main study parameters/endpoints: Liver enzymes (GGT, ALAT, ASAT), blood pressure, glucose, insulin, haematology and serum clinical chemical profile
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | purple sweet potato (PSP)-juice | Daily oral intake of 3x 125 ml of PSP-juice or control juice |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2009-08-19
- Last updated
- 2010-04-14
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00962195. Inclusion in this directory is not an endorsement.